APS2 Antibody

Shipped with Ice Packs
In Stock

Description

Antiphospholipid Syndrome (APS) Antibody Profiles

APS is characterized by thrombotic/obstetric complications linked to persistent antiphospholipid antibodies (aPL). While "APS2" is not a formal classification, research identifies distinct antibody profiles influencing clinical risk:

Key Antibody Classes in APS

Antibody TypeTarget AntigenClinical RelevanceDetection Method
Lupus anticoagulant (LA)Phospholipid-protein complexesStrongest thrombotic risk predictor Coagulation assays (dRVVT, aPTT)
Anti-β2 glycoprotein I (aβ2GPI)Domain I of β2GPIHigh specificity for APS; correlates with arterial thrombosis ELISA/Chemiluminescence (IgG/IgM)
Anticardiolipin (aCL)Cardiolipin-β2GPI complexesLower specificity; common in transient infections ELISA (IgG/IgM)
Anti-phosphatidylserine/prothrombin (aPS/PT)PS/PT complexesSurrogate marker for LA positivity; emerging diagnostic utility ELISA (IgG/IgM)

Table 1: Diagnostic Thresholds for APS Antibodies

AssayIgG Positive Threshold (Units)IgM Positive Threshold (Units)
aCL (ELISA)>14.4 GPL-U/mL>7.2 MPL-U/mL
aβ2GPI (ELISA)>14.4 U/mL>14.4 U/mL
aCL (CLIA)>20 GPL-U/mL>10 MPL-U/mL
aβ2GPI (CLIA)>20 U/mL>10 U/mL

Critical Findings:

  • Triple positivity (LA + aCL + aβ2GPI) confers the highest thrombotic risk (OR 33.3 vs single positivity) .

  • Anti-β2GPI domain I IgG antibodies show 98% specificity for APS and correlate with obstetric complications .

  • aPS/PT IgM demonstrates 71% sensitivity for catastrophic APS (CAPS), outperforming conventional markers .

Autoimmune Polyglandular Syndrome Type II (APS-II) Antibodies

APS-II involves autoimmune endocrine disorders (Addison’s disease, thyroiditis, diabetes). Antibody associations include:

Table 2: Autoantibody Prevalence in APS-II

Autoantibody TargetPrevalenceClinical Association
Thyroid peroxidase (TPO)67.6%Hashimoto’s thyroiditis
TSH receptor58%Graves’ disease
Glutamic acid decarboxylase (GAD65)51.8%Type 1 diabetes
Adrenal cortex9.7%Addison’s disease
Ovarian tissue8.8%Premature ovarian failure

Mechanistic Insights:

  • Antibody diversity reflects epitope spreading across endocrine tissues over decades (mean latency: 12 years between first/second autoimmune diagnoses) .

  • Anti-GAD65 IgG levels >200 IU/mL predict rapid β-cell loss in APS-II-related diabetes .

Research Gaps and Emerging Directions

  1. Pathogenicity Gradients: Low-affinity germline aPL exist naturally, but somatic hypermutation (e.g., HL5B → HL7G transition ) drives pathogenic β2GPI specificity.

  2. Seronegative APS Biomarkers: 53% of seronegative APS patients show positivity for non-criteria antibodies (aPS/PT, anti-annexin A5) .

  3. Assay Standardization: Inter-method discordance remains significant (e.g., CLIA vs ELISA thresholds in Table 1) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
APS2 antibody; ASA1 antibody; MET3-1 antibody; At1g19920 antibody; F6F9.2ATP sulfurylase 2 antibody; EC 2.7.7.4 antibody
Target Names
APS2
Uniprot No.

Target Background

Database Links

KEGG: ath:AT1G19920

STRING: 3702.AT1G19920.1

UniGene: At.24657

Protein Families
Sulfate adenylyltransferase family
Subcellular Location
[Isoform 1]: Plastid, chloroplast.; [Isoform 2]: Cytoplasm.
Tissue Specificity
Mostly expressed in leaves or cotyledons.

Q&A

What are the storage and handling recommendations for APS2 antibodies?

APS2 antibodies are typically provided in lyophilized form and require specific storage conditions to maintain their activity and specificity . Upon receipt, the product should be immediately stored at the recommended temperature. Researchers should use a manual defrost freezer and avoid repeated freeze-thaw cycles which can degrade antibody quality and reduce sensitivity . When handling the lyophilized antibody, it's advisable to reconstitute only the amount needed for immediate experiments to minimize degradation. During experiments, the antibody solution should be kept on ice and used within the timeframe specified by the manufacturer. Proper storage and handling protocols are essential for maintaining antibody performance and experimental reproducibility.

How does APS2 antibody specificity compare with other ATP sulfurylase isoform antibodies?

The specificity of APS2 antibodies is influenced by the high sequence homology between ATP sulfurylase isoforms. According to research data, the synthetic peptide used for immunization of APS2 antibody (PHY2849A) shows 100% homology with the sequence in APS1 (AT3G22890) and 94% homology with sequences in APS3 (AT4G14680) and APS4 (AT5G43780) . This high sequence similarity means that some APS2 antibodies may cross-react with other ATP sulfurylase isoforms, potentially complicating the interpretation of experimental results. Researchers must carefully validate antibody specificity in their specific experimental system, potentially using knockout mutants or recombinant protein standards to confirm target specificity. Selecting antibodies raised against unique epitopes or using multiple antibodies targeting different regions can help distinguish between these closely related proteins.

What validation steps should researchers take when using APS2 antibodies?

Validation of APS2 antibodies is crucial for ensuring experimental reliability. Researchers should first perform Western blot analysis using positive and negative controls to confirm antibody specificity. Positive controls might include recombinant APS2 protein or extracts from tissues known to express APS2, while negative controls could include extracts from aps2 knockout mutants. Given the high sequence homology between APS isoforms, researchers should also test for cross-reactivity with other ATP sulfurylase proteins (APS1, APS3, APS4). Additional validation approaches include immunoprecipitation followed by mass spectrometry to confirm target identity, immunohistochemistry with appropriate controls, and comparing antibody reactivity patterns with known expression data. Maintaining detailed records of validation experiments is essential for ensuring reproducibility and interpreting results accurately.

What experimental factors affect APS2 antibody performance in Western blotting?

Multiple experimental factors can significantly impact APS2 antibody performance in Western blotting. Sample preparation is critical - proteins must be effectively extracted from plant tissues using buffers that maintain APS2 stability and native conformation. The choice of reducing agents, detergents, and protease inhibitors in extraction buffers can affect epitope availability. Transfer conditions (wet versus semi-dry, buffer composition, membrane type) influence protein binding to membranes. Blocking reagents should be optimized to reduce background while maintaining specific binding. Primary antibody concentration and incubation conditions (time, temperature, buffer composition) directly affect signal strength and specificity. Secondary antibody selection must be compatible with the detection system and primary antibody species. Finally, the detection method (colorimetric, chemiluminescent, or fluorescent) affects sensitivity and dynamic range of signal detection.

How can researchers optimize immunolocalization protocols using APS2 antibodies?

Optimizing immunolocalization with APS2 antibodies requires systematic adjustment of multiple protocol parameters. Fixation methods significantly impact epitope preservation - researchers should compare crosslinking fixatives (paraformaldehyde) with precipitating fixatives (acetone, methanol) to determine which best preserves APS2 antigenicity while maintaining tissue structure. Antigen retrieval methods (heat-induced, enzymatic, or pH-mediated) may be necessary to expose epitopes masked during fixation. Permeabilization conditions should be optimized to allow antibody access while preserving cellular structure. Blocking solutions must effectively reduce non-specific binding without interfering with antibody-antigen interactions. Primary antibody dilution series should be tested to determine optimal concentration, and incubation conditions (duration, temperature) systematically evaluated. Detection systems (fluorescent or enzymatic) should be selected based on the required sensitivity and whether multicolor imaging is needed.

Which plant species show cross-reactivity with APS2 antibodies?

APS2 antibodies demonstrate significant cross-reactivity across diverse plant species, making them valuable tools for comparative studies. Based on experimental data, APS2 antibody PHY2847A shows cross-reactivity with numerous species spanning monocots and dicots, including Arabidopsis thaliana, Brassica species (napus, rapa), legumes (Glycine max, Medicago truncatula), Nicotiana tabacum, Spinacia oleracea, Vitis vinifera, Cucumis sativus, Populus trichocarpa, and cereals (Hordeum vulgare, Setaria viridis, Panicum virgatum, Sorghum bicolor, Triticum aestivum, Zea mays, Oryza sativa) . This broad cross-reactivity indicates conservation of the epitope regions across evolutionarily diverse plant taxa. The PHY2848S variant shows more limited cross-reactivity, primarily with Brassicaceae family members (Arabidopsis thaliana, Brassica rapa, Brassica napus) .

What is the cross-reactivity table for different APS2 antibody variants?

Antibody VariantCross-Reactive SpeciesKey Applications
PHY2847ABroad range: Arabidopsis, Brassica species, legumes, tobacco, spinach, grapevine, cucumber, poplar, and numerous cerealsComparative studies across diverse plant families
PHY2848SLimited range: Arabidopsis thaliana, Brassica rapa, Brassica napusBrassicaceae-specific studies requiring minimal cross-reactivity
PHY2849AExtensive range: All species in PHY2847A plus Physcomitrium patens, Solanum tuberosum, Solanum lycopersicumStudies requiring detection of multiple ATP sulfurylase isoforms

This cross-reactivity data helps researchers select the appropriate antibody variant based on their specific experimental needs and target species .

How can researchers predict potential cross-reactivity in untested species?

Predicting cross-reactivity in untested plant species involves several complementary approaches. Researchers should first perform sequence alignment analysis of the target epitope region across species of interest, as higher sequence homology typically correlates with greater likelihood of cross-reactivity. Phylogenetic analysis can help identify evolutionary relationships that might predict cross-reactivity patterns based on known reactivity in related species. Western blot testing with titrated antibody concentrations on samples from the species of interest remains the gold standard for confirming cross-reactivity. Epitope mapping data, when available, can improve prediction accuracy by identifying the specific amino acid residues critical for antibody binding. Researchers might also consider computational approaches like epitope prediction algorithms that account for protein structure and amino acid properties to estimate binding potential in new species.

How can APS2 antibodies be used to study plant responses to environmental stressors?

APS2 antibodies are valuable tools for investigating plant sulfur metabolism adaptation to environmental stresses. Under sulfur deficiency conditions, researchers can use APS2 antibodies to track changes in ATP sulfurylase protein levels, providing insights into regulatory mechanisms controlling sulfur assimilation pathway components. Comparative analysis of APS2 protein abundance across different tissues under stress conditions can reveal tissue-specific regulation. Co-immunoprecipitation with APS2 antibodies followed by mass spectrometry can identify stress-induced protein interaction partners. Researchers can combine APS2 protein detection with enzyme activity assays to correlate protein levels with functional changes. Immunohistochemistry with APS2 antibodies can reveal changes in subcellular localization under stress. Time-course experiments tracking APS2 protein dynamics during stress exposure and recovery provide detailed understanding of temporal regulation patterns in sulfur metabolism during environmental challenges.

What techniques can distinguish between different ATP sulfurylase isoforms (APS1-4) despite their sequence homology?

Distinguishing between highly homologous ATP sulfurylase isoforms requires combining multiple technical approaches. Isoform-specific antibodies raised against unique peptide sequences can sometimes differentiate between APS isoforms, though careful validation is essential due to the 94-100% sequence homology noted in the research data . Using genetic approaches with isoform-specific knockout or knockdown lines as controls helps validate antibody specificity. Mass spectrometry following immunoprecipitation can identify isoform-specific peptides for definitive identification. Multiple reaction monitoring (MRM) mass spectrometry with isoform-specific peptides allows quantification of different isoforms within complex samples. RNA expression analysis (qRT-PCR, RNA-seq) in parallel with protein detection helps correlate transcript and protein levels for each isoform. Researchers can also perform experimental verification using recombinant proteins of each isoform as standards for antibody reactivity comparisons.

How can APS2 antibodies contribute to understanding the integration of sulfur metabolism with other plant metabolic pathways?

APS2 antibodies enable sophisticated research into the integration of sulfur metabolism with other plant biochemical networks. By combining immunoprecipitation with APS2 antibodies and mass spectrometry, researchers can identify protein interaction partners that link sulfur assimilation to other metabolic pathways. Co-immunolocalization studies using APS2 antibodies alongside markers for other metabolic pathways can reveal potential functional relationships based on subcellular co-localization. Researchers can track changes in APS2 protein levels across different metabolic states (e.g., nitrogen limitation, carbon starvation) to understand cross-regulation between pathways. Chromatin immunoprecipitation (ChIP) experiments with transcription factors followed by APS2 expression analysis can reveal regulatory mechanisms connecting different metabolic networks. Metabolomic profiling coupled with APS2 protein quantification helps correlate enzyme abundance with metabolite levels across multiple pathways. Time-resolved studies tracking protein dynamics during metabolic transitions provide insights into the temporal coordination of integrated metabolic networks.

What are common pitfalls when working with APS2 antibodies and how can they be addressed?

Several challenges can arise when working with APS2 antibodies. Cross-reactivity with other ATP sulfurylase isoforms due to high sequence homology (94-100%) is a significant concern; researchers should validate specificity using recombinant proteins or knockout lines for each isoform. Background signal in Western blots can be addressed by optimizing blocking conditions, antibody concentrations, and wash stringency. Loss of antibody activity may occur with improper storage or excessive freeze-thaw cycles; researchers should aliquot reconstituted antibody and follow manufacturer storage recommendations . Inconsistent results between experiments might stem from variations in sample preparation; standardizing extraction protocols and including consistent positive controls helps ensure reproducibility. False negatives may occur if the epitope is masked by protein interactions or post-translational modifications; alternative extraction conditions or multiple antibodies targeting different epitopes can help. Batch-to-batch variability of antibodies should be managed by maintaining detailed records of validation experiments for each lot received.

What controls are essential when using APS2 antibodies in experimental procedures?

Rigorous experimental design with appropriate controls is crucial when working with APS2 antibodies. Positive controls should include samples known to contain APS2 protein, such as tissues with validated expression or recombinant APS2 protein standards. Negative controls are equally important - samples from aps2 knockout/knockdown plants or tissues known not to express APS2 help confirm specificity. Loading controls (housekeeping proteins) are essential for normalizing protein amounts across samples. Antibody specificity controls include pre-immune serum tests and peptide competition assays, where the antibody is pre-incubated with the immunizing peptide before application. Technical controls such as secondary-antibody-only conditions help identify non-specific binding. When investigating isoform specificity, parallel detection with antibodies targeting other ATP sulfurylase isoforms is valuable. For quantitative applications, standard curves using purified recombinant protein should be included to ensure measurements fall within the linear detection range.

How should researchers approach quantitative analysis when using APS2 antibodies?

Quantitative analysis with APS2 antibodies requires careful methodology to ensure accuracy and reproducibility. Researchers should first establish the linear detection range for their specific antibody and detection system using standard curves with recombinant APS2 protein. Sample loading must be carefully normalized using total protein measurements and verified with housekeeping protein controls. For Western blot quantification, technical replicates (multiple lanes of the same sample) and biological replicates (independent biological samples) are necessary for statistical validity. Image acquisition parameters must be optimized to avoid signal saturation, which compromises quantification accuracy. Densitometry software settings should be standardized across experiments, with background subtraction methods clearly documented. For complex comparisons, researchers should consider using fluorescently-labeled secondary antibodies that offer greater linear dynamic range than chemiluminescent methods. When comparing samples across multiple blots, inclusion of a common reference sample on each blot allows for inter-blot normalization.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.